MedXT (YC W13) Announces FDA-Cleared Medical Image Platform
techcrunch.com
techcrunch.com
In my experience, healthcare and medical science are so difficult that the cost of the regulatory burden is a rounding error when you consider the amount of due diligence you have to do to make sure you don't badly mess up someone's life/health.
The two are completely different.
If you're making stuff like pacemakers that keep people alive while implanted in their body, the vast majority of that cost will be unavoidable if you don't want to risk killing a bunch of people (which is, you know, a thing worth paying for).
I'm just pointing out that all of your anecdotal stories were related to practice, not device development.
As for my anecdotes, I worked on bringing online robotics and brand new diagnostic tests (with and without golden standards) which are under entirely different regulations than record keeping or the day to day operations of a lab.
But this is the medical equivalent of Notepad. It is lacking a ton of critical features, which makes it inadequate for almost any real use cases.
The regulatory burden is substantially lower when you don't have much functionality.
Also, $2 per case is way too expensive for what they're offering.
Source: I worked in competing products for a decade.
EDIT: Looks like they're moving in a decent direction, though:
https://news.ycombinator.com/item?id=8038386
EDIT EDIT: I'm not as impressed with the "volume rendering" as I wanted to be. So, time will tell. I wish them luck.
Jonathan Bush, CEO of athenahealth, recently ranted at congress about excessive healthcare regulation. His frustration was palpable: https://www.youtube.com/watch?v=CekfvGDiab8
From the perspective of consumers I'd say this is not exactly a silver lining. (Though obviously I don't think you were suggesting that the excessive regulation is a good situation overall, just that at least there's some incentive for startups to power through.)
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidanc...
This ISN'T: novel drug/algorithm/X --causes-better--> patientoutcome, which would acquire trial/approval.
This IS: things we do now, except in the cloud, so you don't have to keep two IT guys on hand even in the graveyard shift - "virtualization".
Disclosure: I've worked with some serious venture backed (50MM+) companies doing almost exactly this. I would love to give you a full heads up on what to expect. But making excellent scheduling alone is an incredibly difficult feat. Our team spent considerable time working with the absolutely top imaging facilities in the US just to get scheduling down to a science.
Go destroy those big guys! (AGFA/Fuji/GE etc)
Yes, we're currently integrating "The X Toolkit" from Boston Children's: http://www.goxtk.com/ It should be ready in October/November.
http://www.ehealthtechnologies.com/solutions/health-informat...
We'd need to know a bit more about what this company offers to answer that question. On its surface... it doesn't look like much more than what other companies already put out.